Effects of a 9-months Treatment of SPIRIVA on Health Related Quality of Life in Patients With COPD
Status:
Completed
Trial end date:
2004-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the effect of a 9-month treatment of tiotropium
(SPIRIVA®) 18 mcg once daily on Health Related Quality of Life and lung function in patients
with a Chronic Obstructive Pulmonary Disease.